In conclusion, by systematically analyzing the gene expression landscape of 24 m6A regulators in pan-cancer, IGF2BP2 was found to be highly expressed in HNSCC, is correlated with tumor progression and a low survival rate, and is involved in tumor immune invasion. The gene discussed is IGF2BP2; the disease is cancer.